CHEST

Health care professionals can leverage their expertise to protect patients by driving practical, equitable clean air solutions. Learn how in the latest CHEST Physician: hubs.la/Q049z1Wy0

Eduardo Solbes, MD, joins CHEST® Journal Podcast Moderator Matt Siuba, DO, MS, to discuss his research into the variation in full MIST2 regimen dosing of intrapleural enzyme therapy across 21 hospitals in adults hospitalized with complicated parapneumonic effusion or empyema.  Listen now: hubs.la/Q047DwdF0 #MedEd #JournalCHEST #Podcast

INSIDE LOOK 👀 Read more of the latest research from the upcoming issue (April 8): A scoping review in the journal CHEST® explores the trends and evidence related to new medical devices across chest medicine. Read the article in the April issue of the journal CHEST®: hubs.la/Q047dvtt0 #MedEd #JournalCHEST

📖 AI tools like OpenEvidence are changing how critical care clinicians learn, study, and practice medicine in the ICU. Read the full article in CHEST Physician: hubs.la/Q049yWdf0

INSIDE LOOK 👀 Read from the upcoming issue (April 8): Original research findings support disease stability as a clinically meaningful and achievable treatment target in COPD, with potential utility in guiding personalized disease management. Read more in the April issue of the journal CHEST®: hubs.la/Q047dsf00 #MedEd #JournalCHEST #COPD

INSIDE LOOK 👀 Read more of the latest research from the upcoming issue (April 8): What are the characteristics of inspiratory effort and transpulmonary driving pressure in extremely preterm infants undergoing noninvasive ventilation? Read the research in the April issue of the journal CHEST®: hubs.la/Q0477-4c0 #MedEd #JournalCHEST #CriticalCare #CritCare

INSIDE LOOK 👀 Read more of the latest research from the upcoming issue (April 8): What are the prevalence and clinical implications of fungal sensitization in bronchiectasis? Read the original chest infections research in the April issue of the journal CHEST®: hubs.la/Q0477WRh0 #MedEd #JournalCHEST

Put your COPD knowledge to the test. Play the game: hubs.la/Q0477BdG0

Learn about core critical care topics addressed in the CHEST Critical Care APP Certification (CCAPP) Exam. Join us in person at CHEST Headquarters or attend the livestreamed sessions from home. hubs.la/Q044xZ8T0

Board review registration is now open! Study for your ABIM certification exam and expand your clinical knowledge with CHEST's expert-led course. Reserve your spot today: hubs.la/Q0499trX0

Discover how leading experts in the field discuss aspects of treatment for stage III NSCLC, with special emphasis on the multidisciplinary approach. Watch the webinar: hubs.la/Q046ydNl0 #CancerControlMonth #LungHealth

Real science doesn’t end with publication. Thomas Valley, MD, MS, shares how he advocates for systemwide change based on his research in pulse oximeter inaccuracies and encourages other clinicians to ask important questions that will improve patient care: hubs.la/Q049l_S70

INSIDE LOOK 👀 Read from the upcoming issue (April 8): Original research findings show that structural and functional MRI measurements in people with cystic fibrosis (CF) were associated with future exacerbations, likely because they directly measure underlying structural and functional aspects of disease. Read more in the journal CHEST®: hubs.la/Q0477Lp90 #MedEd #JournalCHEST #CysticFibrosis #CF

Four clinicians and scientists share their experiences with advocacy in the medical arena, from turning points in their own careers to starting points for colleagues. Read the story in CHEST Advocates: hubs.la/Q049lZKg0

INSIDE LOOK 👀 Read more of the latest research from the upcoming issue (April 8): Original research explores the current treatment patterns for patients with newly diagnosed pulmonary arterial hypertension (PAH) in the Pulmonary Hypertension Association Registry (PHAR). Read more in the April issue of the journal CHEST®: hubs.la/Q047rlx80 #MedEd #JournalCHEST

INSIDE LOOK 👀 Read more of the latest research from the upcoming issue (April 8): Can short-term trajectories of neoepitopes after initiation of antifibrotic treatment predict therapy-related outcomes, including mortality, in patients with idiopathic pulmonary fibrosis (IPF)? Read the original research in the April issue of the journal CHEST®: hubs.la/Q047mBwc0 #MedEd #JournalCHEST #LungDisease #PulmonaryFibrosis #IPF

Physician advocate and new CHEST Advocates Editor in Chief Panagis Galiatsatos, MD, MPH, explains why advocacy is essential to improving community health, advancing science, and helping clinicians be conduits for change. Read his letter today: hubs.la/Q049gvfb0 #CHESTAdvocates

Our powerful database helps clinicians quickly connect with right heart catheterization specialists nearby—simplifying referrals and reducing delays. Start your search now: hubs.la/Q048Z8xr0

INSIDE LOOK 👀 Read more of the latest research from the upcoming issue (April 8): Original research indicates that exertional dyspnea is associated with moderate and severe OSA, potentially due to heightened autonomic and cortical responses to increased respiratory efforts. Read more in the April issue of the journal CHEST®: hubs.la/Q046N7YT0 #MedEd #JournalCHEST #SleepMed #OSA

INSIDE LOOK 👀 Read from the upcoming issue (April 8): Original research shows that Veterans Health Administration clinicians reported predominantly negative perceptions of the 2021 inhaler formulary change from budesonide-formoterol metered-dose inhaler to fluticasone-salmeterol dry-powder inhaler, underscoring the importance of timely clinician communication, patient education, and specialty engagement in future formulary transitions. Read more: hubs.la/Q046N0MR0 #MedEd #JournalCHEST